Task: Answer the multiple-choice question.
Question: Which compound exhibits a -9.535% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
[a] NC(=O)N/N=C/c1ccccc1OCc1cccc2ccccc12
[b] C=CCc1ccc(OC(=O)NC2CCCCC2)c(OC)c1
[c] CC(=O)c1c(C)[nH]c(C(=O)OCc2ccccc2F)c1C
[d] CC(=O)Nc1cc(-c2nn3c(C)nnc3s2)ccc1C
[e] CC1CCCN(CC(=O)Nc2cc(S(=O)(=O)N3CCOCC3)ccc2N2CCCC2)C1
Answer: e. CC1CCCN(CC(=O)Nc2cc(S(=O)(=O)N3CCOCC3)ccc2N2CCCC2)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCCN(CC(=O)Nc2cc(S(=O)(=O)N3CCOCC3)ccc2N2CCCC2)C1
CC1CCCN(CC(=O)Nc2cc(S(=O)(=O)N3CCOCC3)ccc2N2CCCC2)C1
2-(3-methylpiperidin-1-yl)-N-(5-morpholin-4-ylsulfonyl-2-pyrrolidin-1-ylphenyl)acetamide